HER2 Support Group Forums - XL184, a Phase III inhibitor of MET, VEGFR2 and RET, and XL281

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Articles of Interest (https://her2support.org/vbulletin/forumdisplay.php?f=31)

- - XL184, a Phase III inhibitor of MET, VEGFR2 and RET, and XL281 (https://her2support.org/vbulletin/showthread.php?t=37142)

Rich66

12-13-2008 08:27 PM

XL184, a Phase III inhibitor of MET, VEGFR2 and RET, and XL281

Bristol-Myers Squibb and Exelixis Enter Global Collaboration on Two Novel Cancer Programs

Programs include XL184, a Phase III inhibitor of MET, VEGFR2 and RET, and XL281, a Phase I Inhibitor of RAF Kinase

full article:
http://online.wsj.com/article/SB1229...googlenews_wsj

All times are GMT -7. The time now is 11:08 AM.